Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$3.0M
Filings
36
Firms Hired
5
Active Period
2023–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 6214
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 7352
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $200,000 · Firm income: —
Matched citations: S. 2730
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $200,000 · Firm income: —
Matched citations: S. 4815
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $110,000 · Firm income: —
Matched citations: H.R. 6214
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $110,000 · Firm income: —
Matched citations: H.R. 7352
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $110,000 · Firm income: —
Matched citations: S. 2730
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $110,000 · Firm income: —
Matched citations: S. 4815
Kidney Care Access Protection Act
2026 · second_quarter · Firm: CORMEDIX, INC.
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $220,000 · Firm income: —
Matched citations: H.R. 6214
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $220,000 · Firm income: —
Matched citations: H.R. 7352
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $220,000 · Firm income: —
Matched citations: S. 2730
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $220,000 · Firm income: —
Matched citations: S. 4815
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $380,000 · Firm income: —
Matched citations: H.R. 6214
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $380,000 · Firm income: —
Matched citations: H.R. 7352
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $380,000 · Firm income: —
Matched citations: S. 2730
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $380,000 · Firm income: —
Matched citations: S. 4815
Preserving Patient Access to Home Infusion Act
2025 · fourth_quarter · Firm: CORMEDIX, INC.
H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act
Client expense: $150,000 · Firm income: —
Matched citations: H.R. 2172
Kidney Care Access Protection Act
2025 · fourth_quarter · Firm: CORMEDIX, INC.
H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act
Client expense: $150,000 · Firm income: —
Matched citations: H.R. 6214
Preserving Patient Access to Home Infusion Act
2025 · fourth_quarter · Firm: CORMEDIX, INC.
H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act
Client expense: $150,000 · Firm income: —
Matched citations: S. 1058
H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act
Client expense: $150,000 · Firm income: —
Matched citations: S. 2730
S. 2730, Kidney Care Access Protection Act H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention.
Client expense: $150,000 · Firm income: —
Matched citations: S. 2730
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
2024 · fourth_quarter · Firm: CORMEDIX, INC.
H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 5074, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 S. 4469, A bill to improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes S. 4510 - The Kidney Patient Act Issues related to patient access to infection prevention.
Client expense: $150,000 · Firm income: —
Matched citations: H.R. 5027
H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 5074, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 S. 4469, A bill to improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes S. 4510 - The Kidney Patient Act Issues related to patient access to infection prevention.
Client expense: $150,000 · Firm income: —
Matched citations: H.R. 5074
Chronic Kidney Disease Improvement in Research and Treatment Act of 2024
2024 · fourth_quarter · Firm: CORMEDIX, INC.
H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 5074, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 S. 4469, A bill to improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes S. 4510 - The Kidney Patient Act Issues related to patient access to infection prevention.
Client expense: $150,000 · Firm income: —
Matched citations: S. 4469
H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 5074, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 S. 4469, A bill to improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes S. 4510 - The Kidney Patient Act Issues related to patient access to infection prevention.
Client expense: $150,000 · Firm income: —
Matched citations: S. 4510
Source: Senate LDA